Dislcosed are novel calcium release-activated calcium (CRAC) channelinhibitors,methods for preparing them, pharmaceutical compositions containing them, andmethods oftreatment using them. The present dislcosure also relates to methods fortreating non-smallcell lung cancer (NSCLC) with CRAC inhibitors, and to methods for identifyingtherapeuticsfor treating and of diagnosing cancer.